SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

RBC Capital Initiates Coverage On Avid Bioservices with Outperform Rating, Announces Price Target of $21

RBC Capital analyst Sean Dodge initiates coverage on Avid Bioservices (NASDAQ:CDMO) with a Outperform rating and announces Price Target of $21.

· 03/17/2021 07:13
RBC Capital analyst Sean Dodge initiates coverage on Avid Bioservices (NASDAQ:CDMO) with a Outperform rating and announces Price Target of $21.